Consistent with our genetic studies, the human AML1-ETO-fusion-driven cell line Kasumi-1 also demonstrated increased sensitivity to GSK343 at similar IC50 to the murine AML tumors (Fig. S3 a), with marked reduction in liquid culture expansion compared with vehicle control (Fig. 2 d). The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.